Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

St. Jude Medical announces FDA approvals of new pacemakers


Monday, 24 Mar 2014 07:00am EDT 

St. Jude Medical:Approval from U.S. FDA for Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P), which provides additional pacing innovations for physicians to treat patients with heart failure.In addition announced FDA approvals for Assurity pacemaker and Endurity pacemaker families of devices.Quadripolar technology facilitates additional pacing configurations within heart that offer physicians options not available in traditional bipolar systems. 

Company Quote

66.47
-0.2 -0.30%
26 Dec 2014